Tap a claim on the ring to put it at the centre.
← Drug companies pile onto the same few already-validated targets, so…
17 connected korrents · 15 moments on record from 12 Feb 2010 to 6 Aug 2026.
Everything filed under design
design
Everything filed under taste
taste
Everything filed under simplicity
simplicity Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Read this korrent: Drug companies pile onto the same few already-validated targets, so far less of biology gets explored than could be. Drug companies pile onto the same few already-validated targets, so far less of biology gets explored than could be. Last stated 2 months ago
21 Jul 2026
RT
Ruxandra Teslo — holds since 2026-07-21 — tap for who they are
Same subject: The patent system rewards novel chemical matter and not novel biology, so nobody is paid for validating a new drug target. — tap to centre the map on it The patent system rewards novel chemical matter and not novel biology, so nobody is paid for validating a new drug… Last stated 2 months ago
21 Jul 2026
RT
Ruxandra Teslo — holds since 2026-07-21 — tap for who they are
Same subject: The hard part of drug discovery is knowing what to make - which target is worth drugging - not designing the molecule. — tap to centre the map on it The hard part of drug discovery is knowing what to make - which target is worth drugging - not designing the… Last stated 2 months ago
21 Jul 2026
AT
Alex Telford — holds since 2023-12-23 — tap for who they are
RT
Ruxandra Teslo — holds since 2026-07-21 — tap for who they are
Same subject: We have neither the data nor the insight to use machine learning to pick drug targets that succeed in the clinic more often. — tap to centre the map on it We have neither the data nor the insight to use machine learning to pick drug targets that succeed in the clinic… Last stated 3 years ago
25 May 2023
DL
Derek Lowe — holds since 2023-05-25 — tap for who they are
Same subject: The drugs advertised as having AI-discovered targets are aimed at targets people already knew about. — tap to centre the map on it The drugs advertised as having AI-discovered targets are aimed at targets people already knew about. Last stated 2 years ago
13 May 2024
DL
Derek Lowe — holds since 2024-05-13 — tap for who they are
Same subject: Companies do not have sufficient incentives to mitigate the major risks of AI, and competition between them is driving corner-cutting. — tap to centre the map on it Companies do not have sufficient incentives to mitigate the major risks of AI, and competition between… Last stated 2 years ago
15 Feb 2025
MB
Miles Brundage — holds since 2025-02-15 — tap for who they are
Same subject: Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them. — tap to centre the map on it Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while… Last stated 14 years ago
8 Mar 2012
DL
Derek Lowe — holds since 2012-03-08 — tap for who they are
Same subject: The value of an ambitious experiment target is not hitting it but the conversation about what would have to be true to hit it. — tap to centre the map on it The value of an ambitious experiment target is not hitting it but the conversation about what would… Last stated 11 months ago
5 Oct 2025
AC
Albert Cheng — holds since 2025-10-05 — tap for who they are
Same subject: Every new drug has to beat the cheap generics that came before it, and that competition with our own back catalogue is why drug discovery gets harder over time. — tap to centre the map on it Every new drug has to beat the cheap generics that came before it, and that competition with our own back… Last stated 14 years ago
8 Mar 2012
DL
Derek Lowe — holds since 2012-03-08 — tap for who they are
Same subject: A blank chat box is lazy: it violates the first rule of a good user experience, that it is obvious what you can do. — tap to centre the map on it A blank chat box is lazy: it violates the first rule of a good user experience, that it is obvious what you can do. Last stated a year ago
12 May 2025
JZ
Julie Zhuo — holds since 2025-05-12 — tap for who they are
Same subject: A company deserves everyone in it, the chief executive included, to spend as much time as possible in their zone of genius — which is an org design problem. — tap to centre the map on it A company deserves everyone in it, the chief executive included, to spend as much time as possible in their zone… Last stated a year ago
23 Mar 2025
RV
Rahul Vohra — holds since 2025-03-23 — tap for who they are
Same subject: A creative lead's job is to take the idea they think is wrong and try to make it work, because the best ideas come out of developing someone else's. — tap to centre the map on it A creative lead's job is to take the idea they think is wrong and try to make it work, because the best ideas come… Last stated 6 months ago
11 Mar 2026
JK
Jeff Kaplan — holds since 2026-03-11 — tap for who they are
Same subject: After a decade of Swiss minimalism, design is about to swing back to something far more expressive. — tap to centre the map on it After a decade of Swiss minimalism, design is about to swing back to something far more expressive. Last stated 11 months ago
16 Oct 2025
DF
Dylan Field — holds since 2025-10-16 — tap for who they are
Same subject: AI acceleration threatens 'less software': without the constraint of scarce hours, even 37signals will likely build too much. — tap to centre the map on it AI acceleration threatens 'less software': without the constraint of scarce hours, even 37signals will likely… Last stated a month ago
26 Jul 2026
DH
David Heinemeier Hansson — holds since 2026-07-26 — tap for who they are
Same subject: Better design does not mean more design: the most obvious designs are often invisible. — tap to centre the map on it Better design does not mean more design: the most obvious designs are often invisible. Last stated 3 years ago
16 Nov 2023
JZ
Julie Zhuo — holds since 2023-11-16 — tap for who they are
Same subject: A first draft should not be graded good or bad; it is only the material that taste then gets to act on. — tap to centre the map on it A first draft should not be graded good or bad; it is only the material that taste then gets to act on. Last stated a month ago
6 Aug 2026
GS
George Saunders — holds since 2026-08-06 — tap for who they are
Same subject: A lot of people can match a framework for taste; almost nobody can create one, and creating one is the rare skill. — tap to centre the map on it A lot of people can match a framework for taste; almost nobody can create one, and creating one is the rare… Last stated 11 months ago
16 Oct 2025
DF
Dylan Field — holds since 2025-10-16 — tap for who they are
Same subject: A product needs a soul, and for that it needs one person of great taste who is its living, breathing aspect and gets furious about every small detail. — tap to centre the map on it A product needs a soul, and for that it needs one person of great taste who is its living, breathing aspect and… Last stated 17 years ago
12 Feb 2010
KS
Karri Saarinen — holds since 2010-02-12 — tap for who they are
At the centre
Drug companies pile onto the same few already-validated targets, so far less of biology gets explored than could be.
Holds RT Ruxandra TesloRead this korrent →
The patent system rewards novel chemical matter and not novel biology, so nobody is paid for validating a new drug target.
Holds RT Ruxandra Teslo
The hard part of drug discovery is knowing what to make - which target is worth drugging - not designing the molecule.
Holds AT Alex TelfordRT Ruxandra Teslo
We have neither the data nor the insight to use machine learning to pick drug targets that succeed in the clinic more often.
Holds DL Derek Lowe
The drugs advertised as having AI-discovered targets are aimed at targets people already knew about.
Holds DL Derek Lowe
Companies do not have sufficient incentives to mitigate the major risks of AI, and competition between them is driving corner-cutting.
Holds MB Miles Brundage
Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them.
Holds DL Derek Lowe
The value of an ambitious experiment target is not hitting it but the conversation about what would have to be true to hit it.
Holds AC Albert Cheng
Every new drug has to beat the cheap generics that came before it, and that competition with our own back catalogue is why drug discovery gets harder over time.
Holds DL Derek Lowe
A blank chat box is lazy: it violates the first rule of a good user experience, that it is obvious what you can do.
Holds JZ Julie Zhuo
A company deserves everyone in it, the chief executive included, to spend as much time as possible in their zone of genius — which is an org design problem.
Holds RV Rahul Vohra
A creative lead's job is to take the idea they think is wrong and try to make it work, because the best ideas come out of developing someone else's.
Holds JK Jeff Kaplan
After a decade of Swiss minimalism, design is about to swing back to something far more expressive.
Holds DF Dylan Field
AI acceleration threatens 'less software': without the constraint of scarce hours, even 37signals will likely build too much.
Holds
Better design does not mean more design: the most obvious designs are often invisible.
Holds JZ Julie Zhuo
A first draft should not be graded good or bad; it is only the material that taste then gets to act on.
Holds GS George Saunders
A lot of people can match a framework for taste; almost nobody can create one, and creating one is the rare skill.
Holds DF Dylan Field
A product needs a soul, and for that it needs one person of great taste who is its living, breathing aspect and gets furious about every small detail.
Holds KS Karri Saarinen